This topic contains a solution. Click here to go to the answer

Author Question: Non-redeployable durable assets that are dependent upon unique complementary and perfectly ... (Read 53 times)

magmichele12

  • Hero Member
  • *****
  • Posts: 559
Non-redeployable durable assets that are dependent upon unique complementary and perfectly redeployable assets to achieve substantial value-added will typically be organized as
 a. an export trading company
  b. a spot market contract
  c. a vertically integrated firm
  d. an on-going relational contract
  e. a joint stock company.

Question 2

Screening is
 a. actions by the informed party to reveal her true risks
  b. actions by the informed party to conceal her true risks
  c. actions by the uninformed party to uncover the true risks
  d. actions by the uninformed party to conceal the true risks



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

huda

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

c

Answer to Question 2

c




magmichele12

  • Member
  • Posts: 559
Reply 2 on: Jul 1, 2018
:D TYSM


xthemafja

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library